Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Photosensitivity Disorders × Diclofenac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Keratosis, Actinic 6 Pain 3 Lymphoma, Follicular 2 Acute Pain 2 Urinary Bladder Neoplasms 1 Respiratory Aspiration 1 Prostatic Hyperplasia 1 Pneumothorax 1 Pleural Neoplasms 1 Pleural Effusion 1 Photosensitivity Disorders 1 Lung Neoplasms 1 Lower Urinary Tract Symptoms 1 Hematuria 1 Empyema, Pleural 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00204542 2011-08-19

Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head

University Hospital Tuebingen

Phase 4 Completed

Photosensitivity Disorders, Keratosis, Actinic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡